Anthropic's Claude family of AI models is now generally available in Microsoft Foundry on Azure, giving enterprise developers another frontier model they can deploy, manage and govern through ...
A campaign active since last November has been targeting Python developers building Telegram bots with trojanized Pyrogram ...
After discontinuing development of its lead asset, Fulcrum Therapeutics has provided more details on its restructure, with 48 of 57 employees headed out the door. Fulcrum Therapeutics’ restructure ...
With few treatments available for sickle cell disease, encouraging early clinical data for a Fulcrum Therapeutics drug made it one to watch. But another medicine from the same drug class was recently ...
Fulcrum Therapeutics (FULC) lost nearly 50% of its value in extended trading after the company disclosed plans to discontinue the development of its lead asset, pociredir, for sickle cell disease in ...
The oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and organ damage and reduce life expectancy. Sign up here. Pociredir ...
Fulcrum Therapeutics has scrapped its sole clinical-stage program after the FDA took a hard line on the modality following the recent withdrawal of Ipsen’s Tazverik from the U.S. market. Ipsen ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
June 1 (Reuters) - Fulcrum Therapeutics (FULC.O), opens new tab said on Monday it would stop developing its experimental sickle-cell disease drug after the U.S. Food and Drug Administration raised ...
Bob Baron, who founded and ran Fulcrum Publishing for more than four decades, died on April 24 in Denver, Colo. He was 92. Prior to beginning his career in publishing, Baron, who was born in Los ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is working on the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The team is in various stages of ...